ArticleCancer reports (Hoboken, N.J.)2022

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy.

Jack M Cuzick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.